Hyperion DeFi Inc
HYPDHealthcare·Biotechnology·USA·Nano·NASD·Nov 12 • 3:59 PM ET
Price
HYPD against its 20, 50 and 200-day averages54.7% under the 52-week high of 6.00 on 12 Nov 2025. 52-week low 2.34 on 28 Jul 2026. Last 15 sessions, 54.7% high to low
Volume 0.35× normal · the line is the 50-bar volume average
Setup. RS line 3
CANSLIM 3 of 6 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%; Institutional Ownership: Over 50%
VCP 3 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High
Minervini 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 0 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; Average Volume: Over 500K; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 2 of 4 — fails: EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 2 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%) — not on the tape: P/E: Under 25
Value 2 of 4 — fails: Return on Equity: Over +15% — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 1 of 4 — fails: Average Volume: Over 500K; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 0 of 4 — fails: Institutional Ownership: Over 30%; Institutional Transactions: Over +10%; 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 0 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200; Average Volume: Over 500K
Profile
HYPDHyperion DeFi, Inc. is a long-term strategic treasury of Hyperliquid's native token HYPE. The firm provides investors with streamlined access to the Hyperliquid ecosystem and is also developing its proprietary Optejet user-filled device, designed for use with a variety of topical ophthalmic liquids, including artificial tears and lens rewetting products. It operates through the following segments: Ophthalmic Technology and Digital Assets. The Ophthalmic Technology segment focuses on developing eye-care devices and delivery systems for ophthalmic liquids. The Digital Assets segment focuses on managing a strategic treasury of blockchain-based assets and exposure to the Hyperliquid ecosystem. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in Laguna Hills, CA.
| Employees | 9 |
|---|---|
| IPO | Jan 25, 2018 |
| Beta | 2.75 |
| ATR, 14d | 0.27 |
| Rel volume | 0.35 |
| Short float | 9.70% |
| Insider own | 17.53% |
| Inst own | 17.86% |
Snapshot
6 groupsValuation
| Index | - |
|---|---|
| Market Cap | $42.27M |
| Enterprise Value | 41.54M |
| Income | -21.41M |
| Sales | 1.40M |
| Book / share | 6.66 |
| Cash / share | 0.62 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 9 |
| IPO | Jan 25, 2018 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | 1.12 |
| Price / earnings / growth | - |
| Price / sales | 30.19 |
| Price / book | 0.41 |
| Price / cash | 4.38 |
| Price / free cash flow | - |
| Value / cash profit | - |
| Value / sales | 29.67 |
| Quick Ratio | 2.34 |
| Current Ratio | 2.34 |
| Debt / equity | 0.09 |
| Long-term debt / equity | 0.06 |
| Options and short | No / Yes |
Earnings
| Earnings / share | -3.44 |
|---|---|
| Earnings next year | 2.42 |
| Earnings next quarter | 1.69 |
| Earnings this year | 174.47% |
| Earnings next year | -65.43% |
| Earnings growth, 5 years | - |
| Past earnings growth | 47.93% 34.01% |
| Past sales growth | - -16.47% |
| Earnings vs last year | 89.91% |
| Sales vs last year | 3052.03% |
| Earnings vs last quarter | 136.97% |
| Sales vs last quarter | - |
| Earnings | Nov 12 BMO |
| Surprise | -46.64% -59.48% |
Ownership
| Insiders own | 17.53% |
|---|---|
| Insider trades | 0.29% |
| Institutions own | 17.86% |
| Institution trades | -3.83% |
| Return on assets | 7.88% |
| Return on equity | 9.55% |
| Return on capital | 6.18% |
| Gross Margin | - |
| Operating margin | -1095.70% |
| Profit Margin | -1528.45% |
| 20-day average | -5.88% |
| 50-day average | -18.30% |
| 200-day average | -18.53% |
Technical
| Shares out | 15.30M |
|---|---|
| Shares floating | 12.82M |
| Short / float | 9.70% |
| Short ratio | 2.69 |
| Short interest | 1.24M |
| 52-week high | 6.00 -54.7% |
| 52-week low | 2.34 +16.2% |
| Volatility | 8.37% 8.55% |
| Average range | 0.27 |
| Strength index | 42.53 |
| Market sensitivity | 2.75 |
| Relative volume | 0.35 |
| Avg Volume | 462.01K |
| Volume | 159,993 |
Performance
| Perf Week | 6.25% |
|---|---|
| Perf Month | -11.97% |
| Perf Quarter | 0.00% |
| Perf Half Y | -24.86% |
| Perf YTD | -23.60% |
| Perf Year | -49.54% |
| Perf 3Y | -97.19% |
| Perf 5Y | -99.10% |
| Perf 10Y | - |
| Recommendation | 1.00 |
| Target Price | 10.22 |
| Prev Close | 2.71 |
| Price | 2.72 |
| Change % | 0.37% |
Analyst ratings
latest 5 of 5| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Dec 24, 2025 | Initiated | Chardan Capital Markets | Buy | ||
| Dec 16, 2025 | Initiated | Cantor Fitzgerald | Overweight | $4 | +47.1% |
| Nov 18, 2024 | Downgrade | H.C. Wainwright | Buy → Neutral | $12 → $2 | -26.5% |
| Mar 01, 2021 | Initiated | Northland Capital | Outperform | $10 | +267.6% |
| Feb 03, 2020 | Downgrade | Oppenheimer | Outperform → Perform |
Peers
Mkt capInsider trading
11 filings| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Jung Hyunsu | See Remarks | Jun 01 '26 | Buy | 3.70 | 7,000 | 25,920 | 1,384,676 | Jun 02 06:18 PM |
| Jung Hyunsu | See Remarks | Jun 02 '26 | Buy | 3.66 | 1,000 | 3,660 | 1,385,676 | Jun 02 06:18 PM |
| Knox David R. | Chief Financial Officer | Dec 31 '25 | Buy | 3.59 | 27,950 | 100,340 | 327,950 | Jan 05 08:00 AM |
| Strahlman Ellen R | Director | Dec 29 '25 | Buy | 3.60 | 12,112 | 43,603 | 91,161 | Dec 30 04:01 PM |
| Strahlman Ellen R | Director | Dec 29 '25 | Buy | 3.61 | 11,856 | 42,800 | 34,869 | Dec 30 04:01 PM |
| Strahlman Ellen R | Director | Dec 26 '25 | Buy | 3.86 | 3,601 | 13,911 | 79,049 | Dec 30 04:01 PM |
| Strahlman Ellen R | Director | Dec 26 '25 | Buy | 3.86 | 3,311 | 12,777 | 23,013 | Dec 30 04:01 PM |
| Strahlman Ellen R | Director | Dec 18 '25 | Buy | 3.14 | 19,702 | 61,835 | 95,150 | Dec 22 08:15 AM |
| Strahlman Ellen R | Director | Dec 18 '25 | Buy | 3.14 | 18,742 | 58,829 | 75,448 | Dec 22 08:15 AM |
| Walters Happy David | Director | Dec 17 '25 | Buy | 3.02 | 61,930 | 187,152 | 111,930 | Dec 19 07:21 PM |
| GELTZEILER MICHAEL S | Director | Dec 17 '25 | Buy | 3.01 | 30,000 | 90,210 | 88,015 | Dec 19 11:00 AM |
Held by
AUMNews
latest 14 of 200- Hyperion DeFi's $1.23 EPS Rides HYPE's Rally, But Its Real Milestone Is A First Positive Core Operating Quarter (Earnings Whispers)
- Hyperion DeFi Posts Record $39.6 Million Quarter, Core Business Breaks Even (CryptoProwl)
- Hyperion DeFi Reports Q3 2026 Financial Results with Third Consecutive Quarterly Record Net Income, Achieving Breakeven Guidance on Core Operations and Cash Flows (GlobeNewswire)
- Hyperion DeFi's Q3 Test: Can Redeployed Hype Fill The Hole Left By USDH? (Earnings Whispers) -16.61%
- Hyperion DeFi Schedules Third Quarter Earnings Call for Thursday, November 12 at 8:00 a.m. ET (GlobeNewswire)
- Hyperion DeFi Commences Share Buybacks, Retires All Legacy Debt, and Commits to Further Capital Optimization (GlobeNewswire)
- Hyperion DeFi, Anchorage Digital, and HyperLend Together Announce the First Institutional Credit Facility on Hyperliquid (GlobeNewswire) -6.14%
- Hyperion DeFi Supports D3's Frontier Vault Launch, Bringing Internet Domain Priority Access to the Hyperliquid Ecosystem (GlobeNewswire)
- Hyperion DeFi Supports DoubleZero Edge in Launching the Fastest Commercially Available Hyperliquid Data Feeds (GlobeNewswire) +6.38%
- Hyperion DeFi Raises Guidance and Announces $20M Share Repurchase Program (GlobeNewswire) +8.48%
- The $500 Billion Experiment to Build 24/7 Markets on Blockchain (Bloomberg)
- Hyperion DeFi Inc (HYPD) (Q2 2026) Earnings Call Highlights: Strategic Pivot and Treasury ... (GuruFocus.com) +5.20%
- Hyperion Profit More Than Triples to $31M, HYPE Treasury Reaches $133M (CryptoProwl)
- Hyperion DeFi Reports 2Q 2026 Financial Results with Another Record Quarterly Net Income and Strong Operating Momentum (GlobeNewswire)
Quarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-11-12 | 1.230 | 2.305 | 1.230 | 0.81 | 2.00 | 2 |
| 2026Q2 | 2026-08-12 | 0.920 | 2.240 | 0.920 | 0.36 | 1.27 | 2 |
| 2026Q1 | 2026-05-14 | 0.260 | 1.320 | 0.255 | 0.24 | 1.47 | 2 |
| 2025Q4 | 2026-03-26 | -6.290 | -1.570 | -4.673 | 0.50 | 0.70 | 3 |
| 2025Q3 | 2025-11-13 | 0.050 | - | 0.054 | 0.30 | - | - |
| 2025Q2 | 2025-08-13 | -2.500 | - | -2.497 | 0.01 | - | - |
| 2025Q1 | 2025-05-19 | -1.590 | - | -1.591 | 0.01 | - | - |
| 2024Q3 | 2024-11-12 | -8.800 | -10.046 | -9.072 | 0.00 | 0.15 | 4 |
| 2024Q2 | 2024-08-12 | -16.800 | -12.000 | -16.646 | 0.02 | 0.92 | 3 |
| 2024Q1 | 2024-05-15 | -18.400 | -18.000 | -18.748 | 0.01 | 0.71 | 4 |
| 2023Q4 | 2024-03-18 | -14.400 | -13.904 | -14.038 | 2.59 | 0.25 | 4 |
| 2023Q3 | 2023-11-13 | -14.400 | -14.408 | -14.626 | 1.20 | 0.16 | 4 |
| 2023Q2 | 2023-08-10 | -12.800 | -13.840 | -13.054 | 0.00 | 0.00 | 2 |
| 2023Q1 | 2023-05-11 | -12.000 | -15.248 | -12.274 | 0.00 | 0.00 | 2 |
| 2022Q4 | 2023-03-30 | -13.600 | -16.400 | -13.347 | 0.00 | 0.00 | 2 |
| 2022Q3 | 2022-11-10 | -16.800 | -16.400 | -16.884 | 0.00 | 0.00 | 2 |
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| 2018FY | -145.6 | -131.6 | -145.65 | 0.00 | 0.00 |
| 2019FY | -117.6 | -120.96 | -117.95 | 0.00 | 0.00 |
| 2020FY | -75.200 | -79.600 | -75.118 | 2.00 | 0.00 |
| 2021FY | -39.200 | -68.000 | -38.834 | 14.00 | 4.00 |
| 2022FY | -66.400 | -70.000 | -66.594 | 0.00 | 0.00 |
| 2023FY | -52.800 | -54.510 | -53.150 | 3.79 | 0.43 |
| 2024FY | -0.620 | -0.620 | -59.806 | 1.60 | 1.60 |
| 2025FY | -9.400 | -3.060 | -9.400 | 0.81 | 1.04 |
| 2026FY | - | 7.000 | - | - | 7.27 |
| 2027FY | - | 2.420 | - | - | 17.83 |
| 2028FY | - | 1.500 | - | - | 7.01 |
| 2029FY | - | 1.400 | - | - | 63.90 |
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| 2026Q4 | S | 2026-11-12 | 3 | 2 | 0 | 4.17 | 0.90 | 10.50 |
| 2026Q4 | S | 2026-10-31 | 3 | 2 | 0 | 4.17 | 0.90 | 10.50 |
| 2026Q4 | S | 2026-09-08 | 3 | 3 | 0 | 4.17 | 0.90 | 10.50 |
| 2026Q4 | S | 2026-09-07 | 3 | 2 | 1 | 4.00 | 0.60 | 10.50 |
| 2026Q4 | S | 2026-08-17 | 3 | 2 | 1 | 3.90 | 0.60 | 10.50 |
| 2026Q4 | S | 2026-08-13 | 3 | 1 | 1 | 3.40 | 0.60 | 9.00 |
| 2026Q4 | S | 2026-08-10 | 3 | 0 | 1 | 3.33 | 0.40 | 9.00 |
| 2026Q4 | S | 2026-07-28 | 3 | 0 | 1 | 3.33 | 0.40 | 9.00 |
| 2026Q4 | S | 2026-06-29 | 3 | 1 | 2 | 3.33 | 0.40 | 9.00 |
| 2026Q4 | S | 2026-06-05 | 3 | 1 | 2 | 3.37 | 0.40 | 9.00 |
| 2026Q4 | S | 2026-05-14 | 3 | 1 | 2 | 3.37 | 0.40 | 9.00 |
| 2026Q4 | S | 2026-04-29 | 3 | 2 | 0 | 3.13 | 0.90 | 6.00 |
| 2026Q4 | S | 2026-03-26 | 3 | 3 | 0 | 3.13 | 0.90 | 6.00 |
| 2026Q4 | S | 2026-02-13 | 3 | 1 | 0 | 2.67 | 0.80 | 6.00 |
Estimate history
| EPS, annual | -46.675 | -145.646 | -117.95 | -75.118 | -38.834 | -66.594 | -53.15 | -59.806 | -9.399 | -3.44 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| EPS, quarterly | -16.646 | -9.072 | -17.504 | -1.591 | -2.497 | 0.054 | -4.673 | 0.255 | 0.923 | |
| Period | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
| Sales, annual | 0 | 0 | 0 | 2 | 14 | 0 | 0.004 | 0.057 | 0.813 | 1.4 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| Sales, quarterly | 0.023 | 0.002 | 0.028 | 0.015 | 0 | 0.303 | 0.496 | 0.244 | 0.358 | |
| Period | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
| Shares, annual | 0.12 | 0.143 | 0.214 | 0.312 | 0.355 | 0.458 | 0.569 | 1.506 | 8.68 | 15.3 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | MRQ |
| Shares, quarterly | 0.698 | 1.08 | 1.506 | 2.831 | 4.855 | 7.163 | 8.68 | 8.762 | 15.3 | |
| Period | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
Income statement, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1.40 | 0.81 | 0.06 | 0.00 | 0.00 | 14.00 | 2.00 | 0.00 | 0.00 |
| Cost of Goods Sold Incl. D&A | - | 0.30 | 5.06 | 0.79 | 0.31 | 1.82 | 0.90 | 0.02 | 0.02 |
| Gross Profit | - | 0.51 | -5.00 | -0.78 | -0.31 | 12.18 | 1.10 | -0.02 | -0.02 |
| Selling, General and Administrative Excl. Other | 16.40 | 19.49 | 27.67 | 24.62 | 26.60 | 25.08 | 20.89 | 21.29 | 17.24 |
| Research and Development | 0.91 | 1.91 | 13.35 | 12.20 | 13.08 | 14.30 | 13.20 | 14.09 | 11.10 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -15.35 | -18.98 | -32.67 | -25.41 | -26.91 | -12.90 | -19.79 | -21.31 | -17.26 |
| Interest Expense | 0.91 | 1.56 | 2.48 | 2.37 | 1.38 | 0.39 | 0.02 | 0.00 | 0.00 |
| Unusual Expense | 8.12 | 33.88 | 14.83 | 0.00 | 0.00 | -0.46 | -0.01 | - | - |
| Net Income Before Taxes | 6.65 | -45.31 | -49.82 | -27.26 | -28.01 | -12.78 | -19.77 | -21.16 | -17.25 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | 6.65 | -45.31 | -49.82 | -27.26 | -28.01 | -12.78 | -19.77 | -21.16 | -17.25 |
| Net Income From Continuing Operations | 6.65 | -45.31 | -49.82 | -27.26 | -28.01 | -12.78 | -19.77 | -21.16 | -17.25 |
| Net Income | -21.41 | -47.00 | -49.82 | -27.26 | -28.01 | -12.78 | -19.77 | -21.16 | -17.25 |
| EPS (Recurring) | -0.84 | -4.66 | -47.34 | -53.15 | -66.59 | -39.82 | -75.14 | -117.95 | -145.65 |
| EPS (Basic, Before Extraordinaries) | -3.09 | -9.40 | -59.81 | -53.15 | -66.59 | -38.83 | -75.12 | -117.95 | -145.65 |
| EPS (Diluted) | -3.44 | -9.40 | -59.81 | -53.15 | -66.59 | -38.83 | -75.12 | -117.95 | -145.65 |
| EBITDA | - | -18.98 | -31.54 | -24.62 | -26.60 | -12.68 | -19.69 | -21.29 | -17.24 |
| Non-Operating Income (Expense) | 31.03 | 9.11 | 0.16 | 0.52 | 0.28 | 0.05 | 0.03 | 0.15 | 0.00 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 3.86 | 6.37 | 1.70 | 2.50 | 3.77 | 2.89 | 2.48 | 2.51 | 1.62 |
| Price To Sales Ratio | 38.20 | 21.88 | 169.69 | 22,537.25 | - | 7.52 | 63.80 | - | - |
| Gross Margin | - | 62.72 | -8,717.63 | -20,681.49 | - | 86.99 | 55.23 | - | - |
| Operating Margin | -1,095.70 | -2,333.42 | -56,972.46 | -670,885.82 | - | -92.17 | -989.46 | - | - |
| Net Margin | -1,528.45 | -5,777.73 | -86,888.57 | -719,859.94 | - | -91.27 | -988.49 | - | - |
| Shares Outstanding | 15.30 | 8.68 | 1.51 | 0.57 | 0.46 | 0.36 | 0.31 | 0.21 | 0.14 |
| Market Capitalization | 42.27 | 42.27 | 17.59 | 89.23 | 57.91 | 113.71 | 151.37 | 76.61 | 32.69 |
Income statement, quarterly
| Metric | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 | 2024Q3 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.36 | 0.24 | 0.50 | 0.30 | 0.00 | 0.01 | 0.03 | 0.00 |
| Cost of Goods Sold Incl. D&A | - | - | 0.30 | - | 0.08 | 0.08 | 3.32 | 0.42 |
| Gross Profit | - | - | 0.19 | - | -0.08 | -0.06 | -3.29 | -0.42 |
| Selling, General and Administrative Excl. Other | 3.07 | 5.24 | 5.12 | 2.97 | 8.28 | 2.97 | 4.96 | 6.91 |
| Research and Development | 0.06 | 0.29 | 0.19 | 0.37 | 0.67 | 0.67 | 1.75 | 3.18 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -2.71 | -5.04 | -4.93 | -2.67 | -8.35 | -3.03 | -8.24 | -7.33 |
| Interest Expense | 0.23 | 0.23 | 0.22 | 0.22 | 0.53 | 0.58 | 0.53 | 0.60 |
| Unusual Expense | -15.75 | -10.11 | 36.37 | -2.40 | 0.00 | -0.09 | 11.21 | 0.00 |
| Net Income Before Taxes | 30.95 | 8.84 | -39.77 | 6.63 | -8.69 | -3.48 | -19.95 | -7.89 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | 30.95 | 8.84 | -39.77 | 6.63 | -8.69 | -3.48 | -19.95 | -7.89 |
| Net Income From Continuing Operations | 30.95 | 8.84 | -39.77 | 6.63 | -8.69 | -3.48 | -19.95 | -7.89 |
| Net Income | 14.34 | 3.24 | -40.56 | 1.57 | -8.79 | -3.48 | -19.95 | -7.89 |
| EPS (Recurring) | 0.28 | -0.30 | -1.74 | -0.00 | -2.50 | -1.62 | -10.62 | -9.07 |
| EPS (Basic, Before Extraordinaries) | 1.01 | 0.30 | -4.67 | 0.26 | -2.50 | -1.59 | -17.50 | -9.07 |
| EPS (Diluted) | 0.92 | 0.26 | -4.67 | 0.05 | -2.50 | -1.59 | -17.50 | -9.07 |
| EBITDA | -2.71 | -4.99 | -4.93 | -2.82 | -8.28 | -2.96 | -8.03 | -7.04 |
| Non-Operating Income (Expense) | 18.15 | 4.00 | 1.76 | 7.12 | 0.19 | 0.04 | 0.03 | 0.05 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 1.63 | 1.80 | 1.77 | -1.35 | 5.67 | 0.28 | 0.16 | 0.45 |
| Price To Sales Ratio | 38.20 | 41.96 | 37.99 | 803.20 | 821.96 | 35.90 | 232.23 | 1,128.86 |
| Gross Margin | - | - | 38.89 | - | - | -413.85 | -11,702.21 | -25,840.00 |
| Operating Margin | -757.51 | -2,063.53 | -993.86 | -881.13 | - | -20,588.95 | -29,342.66 | -451,195.51 |
| Net Margin | 4,009.05 | 1,324.56 | -8,173.28 | 520.16 | - | -23,665.31 | -71,031.15 | -485,406.34 |
| Shares Outstanding | 15.30 | 8.76 | 8.68 | 7.16 | 4.85 | 2.83 | 1.51 | 1.08 |
| Market Capitalization | 42.27 | 28.20 | 29.09 | 54.55 | 29.92 | 2.31 | 17.59 | 44.62 |
Balance sheet, annual
| Metric | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY | 2017FY |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 6.44 | 2.12 | 14.85 | 22.86 | 19.46 | 28.37 | 14.15 | 19.73 | 5.25 |
| Short Term Receivables | 0.26 | 0.31 | 0.62 | 1.84 | 2.15 | 3.12 | 0.10 | 0.00 | 0.00 |
| Inventories | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.54 | 0.33 | 0.87 | 0.65 | 0.39 | 0.30 | 0.10 | 0.13 | 0.04 |
| Total Current Assets | 7.25 | 2.77 | 16.45 | 25.36 | 22.00 | 31.79 | 14.35 | 19.86 | 5.29 |
| Net Property, Plant & Equipment | 0.42 | 0.72 | 5.04 | 2.59 | 1.27 | 0.40 | 0.23 | 0.04 | 0.03 |
| Total Investments and Advances | 16.35 | 0.00 | 0.00 | 0.00 | 7.88 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 27.53 | 0.00 | 2.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.23 | 0.18 | 5.17 | 3.09 | 0.51 | 1.72 | 0.12 | 0.12 | 0.33 |
| Total Assets | 51.76 | 3.67 | 28.78 | 31.04 | 31.66 | 33.91 | 14.70 | 20.02 | 5.64 |
| Short Term Debt Incl. Current Port. of LT Debt | 0.51 | 10.53 | 5.86 | 0.88 | 7.17 | 0.10 | 0.00 | 0.00 | 0.00 |
| Accounts Payable | 0.32 | 2.20 | 1.75 | 1.43 | 1.61 | 1.46 | 1.54 | 1.51 | 0.25 |
| Other Current Liabilities | 1.87 | 3.31 | 1.92 | 2.20 | 2.39 | 16.64 | 1.37 | 1.59 | 0.31 |
| Total Current Liabilities | 2.70 | 16.05 | 9.53 | 4.51 | 11.17 | 18.20 | 2.91 | 3.10 | 0.55 |
| Long Term Debt | 8.00 | 0.72 | 10.25 | 9.29 | 0.00 | 0.37 | 0.00 | 0.00 | 0.00 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.04 | 0.05 | 0.04 | 0.00 |
| Total Liabilities | 10.70 | 16.76 | 19.78 | 13.80 | 11.19 | 18.60 | 2.96 | 3.14 | 0.55 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 41.06 | -13.10 | 9.00 | 17.23 | 20.47 | 15.30 | 11.74 | 16.88 | 5.09 |
| Total Shareholders Equity | 41.06 | -13.10 | 9.00 | 17.23 | 20.47 | 15.30 | 11.74 | 16.88 | 5.09 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 41.06 | -13.10 | 9.00 | 17.23 | 20.47 | 15.30 | 11.74 | 16.88 | 5.09 |
| Total Liabilities & Stockholders Equity | 51.76 | 3.67 | 28.78 | 31.04 | 31.66 | 33.91 | 14.70 | 20.02 | 5.64 |
| Book Value Per Share | 4.73 | -8.69 | 15.80 | 37.60 | 57.60 | 49.01 | 54.92 | 117.71 | 42.31 |
| Tangible Book Value Per Share | 1.56 | -8.69 | 12.08 | 37.60 | 57.60 | 49.01 | 54.92 | 117.71 | 42.31 |
| Full-Time Employees | 9 | 14 | 57 | 41 | 45 | 34 | 27 | 24 | 13 |
| Price to Book Ratio | 0.41 | -1.34 | 5.65 | 2.85 | 5.56 | 9.89 | 6.53 | 1.94 | 1.33 |
| Return on Assets | -163.50 | -307.07 | -91.15 | -89.36 | -38.98 | -81.35 | -121.89 | -134.48 | -113.04 |
| Return on Equity | -324.08 | - | -207.83 | -148.60 | -71.45 | -146.20 | -147.87 | -157.09 | -126.67 |
| Return on Invested Capital | -92.36 | - | -141.62 | -105.61 | -62.44 | -126.17 | -180.20 | -102.24 | -100.77 |
| Quick Ratio | 2.68 | 0.17 | 1.71 | 5.62 | 1.97 | 1.75 | 4.93 | 6.41 | 9.57 |
| Current Ratio | 2.68 | 0.17 | 1.73 | 5.62 | 1.97 | 1.75 | 4.93 | 6.41 | 9.57 |
Cash flow, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | 6.65 | -45.31 | -49.82 | -27.26 | -28.01 | -12.78 | -19.77 | -21.16 | -17.25 |
| Depreciation | - | 0.00 | 1.13 | 0.78 | 0.31 | 0.22 | 0.10 | 0.02 | 0.02 |
| Other Funds (Non Cash) | -17.96 | 33.46 | 18.91 | 4.12 | 4.86 | 2.38 | 2.48 | 2.51 | 1.62 |
| Funds from Operations | -11.46 | -11.86 | -29.78 | -22.36 | -22.84 | -10.17 | -17.19 | -18.63 | -15.62 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -2.52 | -2.91 | -0.34 | -1.48 | -2.26 | -10.70 | 10.81 | -0.29 | 2.51 |
| Cash from Operating Activities | -13.97 | -14.77 | -30.12 | -23.84 | -25.11 | -20.87 | -6.38 | -18.92 | -13.11 |
| Capital Expenditures | 0.02 | -71.95 | -0.16 | -3.97 | -0.87 | -1.62 | -0.26 | -0.17 | -0.03 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Purchase or Sale of Investments | 45.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 45.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 4.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -33.38 | -71.95 | -0.16 | -3.97 | -0.87 | -1.62 | -0.26 | -0.17 | -0.03 |
| Cash Dividends Paid | -0.89 | -0.89 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 51.09 | 93.54 | 23.06 | 15.53 | 20.20 | 14.73 | 20.88 | 13.51 | 27.62 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 51.09 | 93.54 | 23.06 | 15.53 | 20.20 | 14.73 | 20.88 | 13.51 | 27.62 |
| Proceedsfrom Stock Options | -2.80 | 38.61 | 23.06 | 15.48 | 20.18 | 12.40 | 17.97 | 12.96 | 27.62 |
| Issuance or Reduction of Debt, Net | -0.24 | -1.46 | -5.51 | 4.26 | 1.31 | 6.73 | -0.01 | 0.00 | 0.00 |
| Change in Long Term Debt | -0.24 | -1.46 | -5.51 | 4.26 | 1.31 | 6.73 | -0.01 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 4.87 | 9.48 | 7.50 | 0.46 | 0.00 | 0.00 |
| Reduction of Long Term Debt | -0.24 | -1.46 | -5.51 | -0.61 | -8.18 | -0.77 | -0.48 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | -0.37 | -0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | -0.37 | -0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 49.60 | 91.05 | 17.55 | 19.79 | 21.51 | 21.46 | 20.86 | 13.51 | 27.62 |
| Net Change in Cash | 2.24 | 4.32 | -12.73 | -8.01 | -4.47 | -1.03 | 14.22 | -5.58 | 14.48 |
| Free Cash Flow | -13.95 | -14.77 | -30.28 | -26.68 | -25.98 | -22.49 | -6.65 | -19.09 | -13.14 |
| Preferred Dividends (Cash Flow) | - | -0.89 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 9.64 | 7.38 | 6.44 | 8.22 | 7.53 | 3.93 |
| Short Term Receivables | 0.37 | 0.35 | 0.26 | 0.23 | 0.12 | 0.28 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 2.90 | 1.07 | 0.54 | 0.64 | 1.73 | 0.95 |
| Total Current Assets | 12.91 | 8.80 | 7.25 | 9.09 | 9.39 | 5.16 |
| Net Property, Plant & Equipment | 0.21 | 0.34 | 0.42 | 0.49 | 0.59 | 0.64 |
| Total Investments and Advances | 74.12 | 25.42 | 16.35 | 37.95 | 45.50 | 0.00 |
| Intangible Assets | 25.72 | 35.32 | 27.53 | 35.02 | 0.00 | 0.00 |
| Other Assets | 0.18 | 0.18 | 0.23 | 0.24 | 0.18 | 0.18 |
| Total Assets | 113.14 | 70.07 | 51.76 | 82.79 | 55.66 | 5.98 |
| Short Term Debt Incl. Current Port. of LT Debt | 3.22 | 1.97 | 0.51 | 0.49 | 0.48 | 10.57 |
| Accounts Payable | 0.14 | 0.43 | 0.32 | 1.14 | 0.90 | 1.20 |
| Other Current Liabilities | 2.15 | 2.07 | 1.87 | 2.40 | 8.93 | 3.33 |
| Total Current Liabilities | 5.51 | 4.47 | 2.70 | 4.04 | 10.31 | 15.10 |
| Long Term Debt | 5.70 | 7.10 | 8.00 | 8.00 | 7.99 | 0.60 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 11.20 | 11.57 | 10.70 | 12.03 | 18.30 | 15.70 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 101.93 | 58.49 | 41.06 | 70.75 | 37.36 | -9.71 |
| Total Shareholders Equity | 101.93 | 58.49 | 41.06 | 70.76 | 37.36 | -9.71 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 101.93 | 58.49 | 41.06 | 70.76 | 37.36 | -9.71 |
| Total Liabilities & Stockholders Equity | 113.14 | 70.07 | 51.76 | 82.79 | 55.66 | 5.98 |
| Book Value Per Share | 6.66 | 6.68 | 4.73 | 9.88 | 7.70 | -3.43 |
| Tangible Book Value Per Share | 4.98 | 2.65 | 1.56 | 4.99 | 7.70 | -3.43 |
| Full-Time Employees | - | - | 9 | - | - | - |
| Price to Book Ratio | 0.41 | 0.73 | 0.36 | 1.25 | -3.02 | 0.32 |
| Return on Assets | 7.88 | -86.76 | -163.50 | -48.31 | -107.21 | -263.55 |
| Return on Equity | 9.55 | -135.26 | -324.08 | -68.49 | -228.74 | - |
| Return on Invested Capital | 28.76 | 13.48 | -81.05 | 8.41 | -19.16 | - |
| Quick Ratio | 2.34 | 1.97 | 2.68 | 2.25 | 0.91 | 0.34 |
| Current Ratio | 2.34 | 1.97 | 2.68 | 2.25 | 0.91 | 0.34 |
Cash flow, quarterly
| Metric | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 |
|---|---|---|---|---|---|---|
| Net Income | 30.95 | 8.84 | -39.77 | 6.63 | -8.69 | -3.48 |
| Depreciation | - | - | 0.00 | -0.15 | 0.08 | 0.08 |
| Other Funds (Non Cash) | -33.20 | -11.55 | 37.44 | -10.64 | 5.99 | 0.67 |
| Funds from Operations | -2.25 | -2.71 | -2.33 | -4.16 | -2.62 | -2.74 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -0.64 | -1.49 | -1.73 | 1.34 | -0.83 | -1.70 |
| Cash from Operating Activities | -2.90 | -4.20 | -4.06 | -2.82 | -3.45 | -4.44 |
| Capital Expenditures | -9.92 | -1.47 | -71.95 | 0.02 | -0.02 | 0.00 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 0.00 | 0.00 | 65.64 | -20.14 | -45.50 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 65.64 | -20.14 | -45.50 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 4.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -5.48 | -1.47 | -6.32 | -20.11 | -45.52 | 0.00 |
| Cash Dividends Paid | 0.00 | 0.00 | -0.80 | -0.10 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | - | - | -0.80 | - | - | 0.00 |
| Change in Capital Stock | 11.17 | 6.67 | 9.53 | 23.72 | 53.88 | 6.41 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 11.17 | 6.67 | 9.53 | 23.72 | 53.88 | 6.41 |
| Proceedsfrom Stock Options | 11.17 | 6.67 | -44.36 | 23.72 | 53.88 | 5.37 |
| Issuance or Reduction of Debt, Net | -0.18 | -0.06 | 0.00 | 1E-06 | -1.31 | -0.15 |
| Change in Long Term Debt | -0.18 | -0.06 | 0.00 | 1E-06 | -1.31 | -0.15 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | -0.18 | -0.06 | 0.00 | 1E-06 | -1.31 | -0.15 |
| Net Financing Active Other Cash Flow | -0.23 | 0.00 | -0.14 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | -0.23 | 0.00 | -0.14 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 10.77 | 6.61 | 8.60 | 23.63 | 52.57 | 6.26 |
| Net Change in Cash | 2.39 | 0.94 | -1.78 | 0.69 | 3.60 | 1.81 |
| Free Cash Flow | -2.90 | -4.20 | -4.06 | -2.80 | -3.47 | -4.44 |
Revenue breakdown
| United States | 2024: 57.34K 2025: 813.46K |
|---|---|
| Digital Assets | 2025: 798.74K |
| Ophthalmic Technology | 2024: 57.34K 2025: 14.72K |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 9.70% | 1.2M | 12.8M | 461.44K |
| 2026-10-15 | 10.11% | 1.3M | 12.8M | 459.29K |
| 2026-09-30 | 8.82% | 1.1M | 12.8M | 451.55K |
| 2026-09-15 | 9.70% | 1.2M | 12.8M | 511.66K |
| 2026-08-31 | 10.28% | 1.3M | 12.8M | 518.79K |
| 2026-08-14 | 12.03% | 1.5M | 12.8M | 478.49K |
| 2026-07-31 | 12.25% | 1.6M | 12.7M | 553.86K |
| 2026-07-15 | 17.57% | 1.5M | 8.7M | 584.18K |
| 2026-06-30 | 15.49% | 1.4M | 8.7M | 578.43K |
| 2026-06-15 | 12.19% | 1.2M | 9.5M | 496.17K |
| 2026-05-29 | 8.08% | 0.8M | 9.5M | 448.46K |
| 2026-05-15 | 10.25% | 0.9M | 9.2M | 401.15K |
| 2026-04-30 | 15.11% | 1.0M | 6.9M | 377.88K |
| 2026-04-15 | 16.30% | 1.1M | 6.9M | 391.12K |
| 2026-03-31 | 17.69% | 1.2M | 6.9M | 381.75K |
| 2026-03-13 | 41.78% | 2.1M | 4.9M | 348.83K |
| 2026-02-27 | 39.01% | 1.9M | 4.9M | 346.53K |
| 2026-02-13 | 38.45% | 1.9M | 4.9M | 353.30K |
| 2026-01-30 | 40.66% | 2.0M | 4.9M | 337.13K |
| 2026-01-15 | 36.89% | 1.8M | 4.9M | 348.93K |
Option chain
expiry 2026-11-13| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| No option chain for this symbol. | ||||||||||
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-12 | 8-K | Current report | 2026-11-12 | SEC |
| 2026-10-05 | SCHEDULE 13G/A | SEC | ||
| 2026-10-02 | 8-K | Current report | 2026-09-28 | SEC |
| 2026-09-30 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-29 | SEC |
| 2026-08-18 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-16 | SEC |
| 2026-08-13 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-08-12 | 8-K | Current report | 2026-08-12 | SEC |
| 2026-07-08 | 8-K | Current report | 2026-07-07 | SEC |
| 2026-07-01 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-30 | SEC |
| 2026-07-01 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-30 | SEC |
| 2026-07-01 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-30 | SEC |
| 2026-07-01 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-30 | SEC |
| 2026-07-01 | 8-K | Current report | 2026-06-30 | SEC |
| 2026-07-01 | SCHEDULE 13G/A | SEC | ||
| 2026-06-05 | 8-K | Current report | 2026-06-05 | SEC |
| 2026-06-02 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-01 | SEC |
| 2026-05-28 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-27 | SEC |
| 2026-05-15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-03-31 | SEC |
| 2026-05-14 | 8-K | Current report | 2026-05-14 | SEC |
| 2026-05-06 | 8-K | Current report | 2026-05-05 | SEC |
| 2026-05-06 | 424B5 | SEC | ||
| 2026-05-05 | ARS | Annual report to security holders. | 2025-12-31 | SEC |
| 2026-05-05 | DEFA14A | Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 | SEC | |
| 2026-05-05 | DEF 14A | Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 | 2026-06-30 | SEC |
| 2026-05-05 | 424B5 | SEC | ||
| 2026-04-17 | PRE 14A | Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 | 2026-06-30 | SEC |
| 2026-04-01 | 4 | Statement of changes in beneficial ownership of securities | 2026-03-30 | SEC |
| 2026-04-01 | SCHEDULE 13G/A | SEC | ||
| 2026-03-30 | 10-K | Annual report pursuant to Section 13 or 15(d) | 2025-12-31 | SEC |
| 2026-03-26 | 8-K | Current report | 2026-03-20 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 29.58K | 2 | 0 | 0 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 611.46K | 9 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 3.08% |
| FRANKLIN TEMPLETON INC | 2.53% |
| Arrington Capital Management, LLC | 1.96% |
| MORGAN STANLEY | 1.57% |
| GEODE CAPITAL MANAGEMENT, LLC | 1.07% |
| Almanack Investment Partners, LLC. | 1.04% |
| JANE STREET GROUP, LLC | 0.95% |
| OPPENHEIMER & CO INC | 0.82% |
| BlackRock, Inc. | 0.75% |
| UBS Group AG | 0.65% |
Funds
| Fund | % owned |
|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 1.92% |
| Putnam Small Cap Value Fund | 1.84% |
| VANGUARD EXTENDED MARKET INDEX FUND | 1.16% |
| Putnam VT Small Cap Value Fund | 0.72% |
| Fidelity Extended Market Index Fund | 0.53% |
| iShares Micro-Cap ETF | 0.22% |
| Fidelity Total Market Index Fund | 0.14% |
| T. Rowe Price Extended Equity Market Index Fund | 0.14% |
| Fidelity Series Total Market Index Fund | 0.13% |
| Fidelity Nasdaq Composite Index Fund | 0.06% |
OakChart. HYPD. Cached 15 minutes. Terms